These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 25727846)

  • 1. Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD.
    Cazzola M; Beeh KM; Price D; Roche N
    Pulm Pharmacol Ther; 2015 Apr; 31():68-78. PubMed ID: 25727846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD.
    Cazzola M; Molimard M
    Pulm Pharmacol Ther; 2010 Aug; 23(4):257-67. PubMed ID: 20381630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease.
    Beeh KM; Beier J
    Adv Ther; 2010 Mar; 27(3):150-9. PubMed ID: 20411368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glycopyrronium bromide is a long-acting inhaled anticholinergic in the treatment of severe COPD].
    Ulrik CS
    Ugeskr Laeger; 2013 Aug; 175(35):1946-8. PubMed ID: 23978116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel bronchodilators for the treatment of chronic obstructive pulmonary disease.
    Matera MG; Page CP; Cazzola M
    Trends Pharmacol Sci; 2011 Aug; 32(8):495-506. PubMed ID: 21683458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.
    Joos GF
    Expert Opin Investig Drugs; 2010 Feb; 19(2):257-64. PubMed ID: 20047505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future of chronic obstructive pulmonary disease management.
    D'Urzo A; Vogelmeier C
    Expert Rev Respir Med; 2012 Jun; 6(3):285-99. PubMed ID: 22788943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchodilators: current and future.
    Cazzola M; Matera MG
    Clin Chest Med; 2014 Mar; 35(1):191-201. PubMed ID: 24507846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aclidinium bromide improves the lung function and reduces dyspnoea in patients with COPD].
    Ulrik CS
    Ugeskr Laeger; 2014 Jul; 176(28):V01130052. PubMed ID: 25291997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with indacaterol and glycopyrronium bromide in the management of COPD: an update on the evidence for efficacy and safety.
    Ridolo E; Montagni M; Riario-Sforza GG; Baroni M; Incorvaia C
    Ther Adv Respir Dis; 2015 Apr; 9(2):49-55. PubMed ID: 25691493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive efficacy of short-acting bronchodilators on dynamic hyperinflation and exercise tolerance in stable COPD patients treated with long-acting bronchodilators.
    Kitaguchi Y; Fujimoto K; Komatsu Y; Hanaoka M; Honda T; Kubo K
    Respir Med; 2013 Mar; 107(3):394-400. PubMed ID: 23245993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term treatment strategy in chronic obstructive pulmonary disease: how to change the course of the disease].
    Devillier P; Salvator H; Roche N; Grassin-Delyle S; Naline E; Dorocant S; Neveu H
    Presse Med; 2014 Dec; 43(12 Pt 1):1368-80. PubMed ID: 25455634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases.
    Beeh KM; Beier J
    Adv Ther; 2009 Jul; 26(7):691-9. PubMed ID: 19609496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
    Wise RA; Tashkin DP
    Am J Med; 2007 Aug; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in COPD disease management with fixed-dose long-acting combination therapies.
    Bateman ED; Mahler DA; Vogelmeier CF; Wedzicha JA; Patalano F; Banerji D
    Expert Rev Respir Med; 2014 Jun; 8(3):357-79. PubMed ID: 24802656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and novel bronchodilators in respiratory disease.
    Spina D
    Curr Opin Pulm Med; 2014 Jan; 20(1):73-86. PubMed ID: 24247039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM; Bollmeier SG; Finnegan PM
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and therapeutics of bronchodilators.
    Cazzola M; Page CP; Calzetta L; Matera MG
    Pharmacol Rev; 2012 Jul; 64(3):450-504. PubMed ID: 22611179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.